Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Johns Hopkins University
Baltimore, Maryland
The records below are financial disclosure and conflict of interest records obtained by ProPublica from the National Institutes of Health and dozens of large public universities across the country. The NIH only has records for researchers who seek or receive its funding.
Total Disclosures: 221
| Name | Type | Company | Disclosed Value | Year Filed |
|---|---|---|---|---|
| Marc Fishman | Conflict of Interest | Mountain Manor Treatment Center | $250,000 - $299,999 | 2017 |
| Alan Evans | Conflict of Interest | Biospective Inc. | $200,000 - $249,999 | 2017 |
| David Gamm | Conflict of Interest | Opsis Therapeutics, LLC | $100,000 - $149,999 | 2016 |
| Victor Velculescu | Conflict of Interest | Personal Genome Diagnostics | $100,000 - $149,999 | 2018 |
| Justin Hanes | Conflict of Interest | Kala Pharmaceuticals, Inc. | $60,000 - $79,999 | 2015 |
| Paul Fisher | Conflict of Interest | Cancer Targeting Systems, Inc. | $60,000 - $79,999 | 2014 |
| Bert Vogelstein | Conflict of Interest | Sysmex Inostics | $60,000 - $79,999 | 2016 |
| Justin Hanes | Conflict of Interest | Graybug Vision | $60,000 - $79,999 | 2016 |
| Justin Hanes | Conflict of Interest | Kala Pharmaceuticals, Inc. | $60,000 - $79,999 | 2016 |
| Stephen Elledge | Conflict of Interest | TSCAN Therapeutics, Inc. | $60,000 - $79,999 | 2019 |
| Justin Hanes | Conflict of Interest | GrayBug, Inc. | $60,000 - $79,999 | 2016 |
| David Gamm | Conflict of Interest | Opsis Therapeutics, LLC | $60,000 - $79,999 | 2018 |
| Justin Hanes | Conflict of Interest | GrayBug, Inc. | $60,000 - $79,999 | 2016 |
| Paul Fisher | Conflict of Interest | Cancer Targeting Systems, Inc. | $60,000 - $79,999 | 2016 |
| Michael Caterina | Conflict of Interest | Merck | $40,000 - $59,999 | 2015 |
| Alan Evans | Conflict of Interest | Biospective Inc. | $20,000 - $39,999 | 2017 |
| Kenneth Pienta | Conflict of Interest | Cue Biopharma | $20,000 - $39,999 | 2017 |
| Ahment Hoke | Conflict of Interest | Disarm Therapeutics, Inc. | $20,000 - $39,999 | 2018 |
| Naresh Punjabi | Conflict of Interest | Resmed Corp | $10,000 - $19,999 | 2015 |
| Anand Venkataraman | Conflict of Interest | CDI Laboratories, Inc. | $10,000 - $19,999 | 2015 |
| Deepa Subramaniam | Conflict of Interest | AstraZeneca, Inc. | $10,000 - $19,999 | 2018 |
| Ulrich Mueller | Conflict of Interest | Decibel Therapeutics, Inc. | $10,000 - $19,999 | 2017 |
| Stephen Liu | Conflict of Interest | AstraZeneca, Inc. | $10,000 - $19,999 | 2018 |
| Abhay Moghekar | Conflict of Interest | Quanterix Corporation | $10,000 - $19,999 | 2018 |
| Stephen Liu | Conflict of Interest | AstraZeneca, Inc. | $10,000 - $19,999 | 2018 |
| Deepa Subramaniam | Conflict of Interest | AstraZeneca, Inc. | $10,000 - $19,999 | 2018 |
| Bert Vogelstein | Conflict of Interest | Sysmex Inostics | $10,000 - $19,999 | 2016 |
| Ulrich Mueller | Conflict of Interest | Decibel Therapeutics, Inc. | $10,000 - $19,999 | 2017 |
| Todd Brown | Conflict of Interest | Theratechnologies Inc. | $10,000 - $19,999 | 2016 |
| Mark Sulkowski | Conflict of Interest | Gilead Sciences, Inc. | $5,000 - $9,999 | 2014 |
| Todd Brown | Conflict of Interest | Gilead | $5,000 - $9,999 | 2015 |
| Edward Acosta | Conflict of Interest | Viiv Healthcare Company | $5,000 - $9,999 | 2015 |
| Matthew Toerper | Conflict of Interest | StoCastic, LLC | $5,000 - $9,999 | 2017 |
| Janet Davis | Conflict of Interest | Allergan | $5,000 - $9,999 | 2018 |
| Susumu Mori | Conflict of Interest | AnatomyWorks | $5,000 - $9,999 | 2018 |
| Susumu Mori | Conflict of Interest | AnatomyWorks | $5,000 - $9,999 | 2018 |
| Nickolas Papadopoulos | Conflict of Interest | Sysmex Inostics | $0 - $4,999 | 2016 |
| Richard Roden | Conflict of Interest | PaxVax Inc. | $0 - $4,999 | 2015 |
| Edward Acosta | Conflict of Interest | Viiv Healthcare Company | $0 - $4,999 | 2015 |
| Gerald Hart | Conflict of Interest | CELL SIGNALING TECHNOLOGY, INC. | 2015 | |
| Hai-Quan Mao | Conflict of Interest | Cancer Targeting Systems, Inc. | 2018 | |
| Charles Della Santina | Conflict of Interest | Labyrinth Devices, LLC | 2016 | |
| Paul Fisher | Conflict of Interest | Cancer Targeting Systems, Inc. | 2016 | |
| Victor Velculescu | Conflict of Interest | Qiagen GmbH | 2019 | |
| Victor Velculescu | Conflict of Interest | Sysmex Corporation | 2019 | |
| Charles Della Santina | Conflict of Interest | Labyrinth Devices, LLC | 2016 | |
| Victor Velculescu | Conflict of Interest | Roche | 2019 | |
| Kenneth Kinzler | Conflict of Interest | PapGene, Inc. | 2015 | |
| Kenneth Kinzler | Conflict of Interest | PapGene, Inc. | 2015 | |
| Suzanne Topalian | Conflict of Interest | Bristol-Myers Squibb Company | 2016 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.